Full Text
Full Text PDF
Abstract
Guzelbulut et al. (1) demonstrated that the aspartate aminotransferase (AST)-platelet ratio index (APRI) may be a useful noninvasive marker in the exclusion of both significant fibrosis and cirrhosis because of the high negative predictive values (NPVs) in chronic hepatitis B (CHB).
Most read articles by the same author(s)
- Ümit Bilge Doğan, Mustafa Salih Akın, Serkan Yalaki, Pelin Demirtürk, A case of tuberculous colitis mimicking Crohn’s disease , Turkish Journal of Gastroenterology: Vol. 25 No. 1 (2014): Turkish Journal of Gastroenterology
- Salih ÇOLAKOĞLU, Ümit Bilge DOĞAN, RESULTS OF SEDATION AND PREMEDICATION DURING UPPER GASTROINTESTINAL ENDOSCOPY , Turkish Journal of Gastroenterology: Vol. 4 No. 4 (1993): Turkish Journal of Gastroenterology
Article Info
Published In
Journal
Turkish Journal of Gastroenterology
Volume / Issue
Volume 25 · Issue 5
Pages
594-595
History
Published Online
October 15, 2014
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Copyright (c) 2014 Ümit Bilge Doğan, Mustafa Salih Akın
Affiliations
Ümit Bilge Doğan
Department of Gastroenterology, Adana Numune Training and Research Hospital, Adana, Turkey
Mustafa Salih Akın
Department of Gastroenterology, Adana Numune Training and Research Hospital, Adana, Turkey
Cite this Article
Doğan, Ümit B., & Akın, M. S. (2014). AST-platelet ratio index cannot be used in the exclusion of significant fibrosis in chronic hepatitis B patients. Turkish Journal of Gastroenterology, 25(5), 594–595. https://doi.org/10.5152/tjg.2014.14062
Outlines